HIGH GRADE FALLOPIAN TUBE SEROUS ADENOCARCINOMA
Clinical trials for HIGH GRADE FALLOPIAN TUBE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE FALLOPIAN TUBE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for HIGH GRADE FALLOPIAN TUBE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-Boosting drug combo takes on Hard-to-Treat ovarian cancer
Disease control OngoingThis pilot study tests two drugs—pembrolizumab (an immunotherapy) and lenvatinib (a targeted enzyme blocker)—in women with platinum-resistant high-grade serous ovarian, fallopian tube, or peritoneal cancer. The goal is to see how these drugs, given alone and together, change immu…
Matched conditions: HIGH GRADE FALLOPIAN TUBE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early trial is testing whether the drug olaparib can shrink tumors in people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer before they have surgery. Fifteen participants will receive olaparib for two cycles, then undergo standard chemotherapy…
Matched conditions: HIGH GRADE FALLOPIAN TUBE SEROUS ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC